Samuel L. Washington, III, MD

Assistant Professor
University of California, San Francisco

Dr. Samuel Washington is a urologic oncologist and Assistant Professory within the Departments of Urology and Epidemiology & Biostatistics at University of California, San Francisco and the San Francisco Veterans Affairs Medical Center. Since joining faculty in 2020, he has been named the Goldberg-Benioff Endowed Professorship in Cancer Biology as well as a UCSF John A. Watson Faculty Scholar and a San Francisco VA Healthcare System Research Development Initiative Grunfeld Scholar to further support his researh focused on understanding how regional disparities in treatment strategies based on race, geography, and socioeconomic factors impact survival outcomes for patients with GU cancers. His collaborative work includes co-investigator and co-principal investigator roles on disparities-related projects funded by the Department of Defense and the Chan Zuckerberg Initiative, leading to peer-reviewed publications in journals including European Urology and JAMA Oncology, and invited presentations at regional, national, and international conferences.

He holds positions including Associate Chair of Diversity, Equity, and Inclusion in the Department of Urology as well as the Helen Diller Family Comprehensive Cancer Center (HDFCCC) Prostate Cancer Program Community Outreach and Engagement Liaison, the HDFCCC Prostate Cancer Program Community Outreach Liaison, and Minority Enrollment and Recruitment into Trials Champion for the GU Oncology Clinical Trials Workgroup He also serves on the NCCN Guidelines for Prostate Cancer Early Detection Panel and several national committees focused on improving health equity including the Association of Community Cancer Centers Bladder Cancer Advisory Committee and Oncology Clinical Pathways Development Teams for Bladder Cancer, Kidney Cancers, Prostate Cancer for the Veterans Health Administration. Through these positions, his efforts have focused on how best to understand the population-level and healthcare system-related factors that interact with race and ethnicity, geography, and social environment to perpetuate disparities in urologic care.

Disclosure information not submitted.

Presentation(s):

• MP28-10: 10-year outcomes in work loss, physical function, and mental health of 6,693 men undergoing primary treatment for prostate cancer

  Saturday, May 14, 2022
  1:00 PM – 2:15 PM

• MP51: Prostate Cancer: Staging

  Sunday, May 15, 2022
  4:30 PM – 5:45 PM

• MP53-03: Effect of Targeted Cores on Risk Stratification in the Era of Image-guided Prostate Biopsy

  Monday, May 16, 2022
  7:00 AM – 8:15 AM